| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $21.7B | $5.1B | $22.1B | $20.4B | $20.6B | $4.6B |
| Cost of Revenue | — | $16.5B | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | $0.6B | $0.7B | $0.6B | $0.5B | $0.5B | $0.4B |
| SG&A Expense | $3.1B | $3.2B | $3.3B | $2.5B | $3.1B | $2.8B |
| Operating Income | $2.2B | $0.8B | $2.3B | $4.5B | $2.6B | $1.2B |
| Net Income | $1.5B | $5.6B | $1.4B | $3.6B | $1.7B | $2.0B |
| EPS (Basic) | $1.74 | $6.24 | $1.61 | $4.19 | $1.92 | $1.02 |
| EPS (Diluted) | $1.72 | $6.15 | $1.58 | $4.10 | $1.87 | $1.00 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $37.2B | $37.4B | $32.8B | $26.1B | $26.2B | $25.1B |
| Current Assets | $8.5B | $9.9B | $18.8B | $9.9B | $11.4B | $8.5B |
| Cash & Equivalents | $1.6B | $4.0B | $10.0B | $3.5B | $3.0B | $3.1B |
| Total Liabilities | $23.1B | $23.0B | $23.8B | $18.0B | $19.1B | $18.5B |
| Current Liabilities | $7.1B | $7.9B | $6.9B | $6.0B | $6.6B | $5.1B |
| Stockholders' Equity | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $0.6B | $2.6B | $1.7B | $2.2B | $1.7B |
| Investing Cash Flow | $-0.3B | $-2.0B | $-0.7B | $1.7B | $-0.7B | $1.1B |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $-4.7B | $-4.6B | $4.6B | $-2.9B | $-1.6B | $-0.7B |